2019
DOI: 10.1016/j.bbrc.2019.03.060
|View full text |Cite
|
Sign up to set email alerts
|

Versatile Pt NCs-based chemotherapeutic agents significantly induce the apoptosis of cisplatin-resistant non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 27 publications
0
13
0
Order By: Relevance
“…Especially with the rising enthusiasm for exploring nanomaterial-bound small-molecule chemotherapeutics, these novel nanomedicines may reduce side effects and drug resistance and improve the fight against cancer in oncology patients. Based on the nature of the activation of PEI-Pt NCs in various tumor cells, including non-small cell lung cancer and malignant hematologic diseases, it would be interesting to investigate whether this novel bomb is also effective against ovarian cancer (25,26). We designed a novel platinum anticancer drug, Polyethyleneimine caged platinum nanoclusters (PEI-Pt NCs), a zero-valent platinum based on nanoparticles.…”
Section: Discussionmentioning
confidence: 99%
“…Especially with the rising enthusiasm for exploring nanomaterial-bound small-molecule chemotherapeutics, these novel nanomedicines may reduce side effects and drug resistance and improve the fight against cancer in oncology patients. Based on the nature of the activation of PEI-Pt NCs in various tumor cells, including non-small cell lung cancer and malignant hematologic diseases, it would be interesting to investigate whether this novel bomb is also effective against ovarian cancer (25,26). We designed a novel platinum anticancer drug, Polyethyleneimine caged platinum nanoclusters (PEI-Pt NCs), a zero-valent platinum based on nanoparticles.…”
Section: Discussionmentioning
confidence: 99%
“…As illustrated in Figure S4, treatment with HA-Pt NCs-NH 2 resulted in the downregulation of c-myc (p < 0.001), which may be partially responsible for the cell cycle arrest and apoptotic tendency of the H1299 cells. Recent studies [18] have shown that Pt NCs, a novel Pt-based chemotherapeutic agent, have the superior inhibitory effects on tumor cell proliferation and induction of apoptosis, possibly via the activation of p53 protein and related signaling pathways. The mechanism of apoptosis is due to the rapid breakdown of Pt nitrogen compounds into corrosive Pt ions, which tends to bind with DNA and proteins, leading to the destruction of DNA.…”
Section: Induced Apoptosis Mechanism Of Ha-pt Ncs-nh 2 For Nsclc Cellsmentioning
confidence: 99%
“…Compared to cisplatin, Pt NCs-based chemotherapeutic agents significantly inhibited the proliferation of NSCLC cells and showed superior inhibitory and apoptotic effects on cisplatin-resistant A549/DDP cells. [18] Therefore, Pt NCs apply an inspiring probability to achieve targeted identification and therapy for NSCLC via forming HA-functioned Pt NCs bioconjugates.…”
Section: Introductionmentioning
confidence: 99%
“…This distinction gives an opportunity to achieve the specific labelling of hematopoietic cells during the disease diagnosis. Recently, we extended this fluorescent probe to label the lung cancer [187]. The classical human lung adenocarcinoma cells were chosen to examine their biological imaging ability (Figure 8).…”
Section: Biological Applications Of Platinum Nanoclustersmentioning
confidence: 99%
“…The problem of drug resistance seriously affects the chemotherapy efficiency and survival rate of patients during the treatment with chemotherapy drugs due to multiple mechanism, such as the lack of effective drug concentration in tumour cells, reduction of drug activity, cell apoptosis changes, and DNA repair pathways. The experimental results illustrated that Pt NCs-based anticancer drug could achieve the excellent induced apoptosis in both cisplatin-resistant A549/DDP and non-cisplatin-resistant A549 cells [187]. More interesting is that cisplatin-resistant A549/DDP showed the superior inhibitory and apoptotic effects than non-cisplatin-resistant A549 cells by the way of activating p53 protein and the related signalling pathway, which could be proved through the apparent endocytosis behaviour by the nucleus of cisplatin-resistant A549/DDP cells.…”
mentioning
confidence: 96%